BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14593571)

  • 21. Management of chronic rhinosinusitis in CF.
    Mainz JG; Koitschev A
    J Cyst Fibros; 2009 Jun; 8 Suppl 1():S10-4. PubMed ID: 19460681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsense mutation R1162X of the cystic fibrosis transmembrane conductance regulator gene does not reduce messenger RNA expression in nasal epithelial tissue.
    Rolfini R; Cabrini G
    J Clin Invest; 1993 Dec; 92(6):2683-7. PubMed ID: 7504691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.
    Mall M; Bleich M; Greger R; Schreiber R; Kunzelmann K
    J Clin Invest; 1998 Jul; 102(1):15-21. PubMed ID: 9649552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population.
    Wang X; Moylan B; Leopold DA; Kim J; Rubenstein RC; Togias A; Proud D; Zeitlin PL; Cutting GR
    JAMA; 2000 Oct; 284(14):1814-9. PubMed ID: 11025834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New information on chronic rhinosinusitis and polyposis nasi].
    Leunig A; Berghaus A
    MMW Fortschr Med; 2005 Sep; 147(39):28-32. PubMed ID: 16245778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staphylococcus aureus and endoscopic sinus surgery.
    Lin A; Busaba NY
    Curr Opin Otolaryngol Head Neck Surg; 2006 Feb; 14(1):19-22. PubMed ID: 16467633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rhinosinusitis in cystic fibrosis].
    Mainz JG; Gerber A; Arnold C; Baumann J; Baumann I; Koitschev A
    HNO; 2015 Nov; 63(11):809-20. PubMed ID: 26495450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis.
    Hauber HP; Manoukian JJ; Nguyen LH; Sobol SE; Levitt RC; Holroyd KJ; McElvaney NG; Griffin S; Hamid Q
    Laryngoscope; 2003 Jun; 113(6):1037-42. PubMed ID: 12782818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis and management of nasal polyposis in cystic fibrosis.
    Mainz JG; Koitschev A
    Curr Allergy Asthma Rep; 2012 Apr; 12(2):163-74. PubMed ID: 23520643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of Staphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence.
    Ulrich M; Herbert S; Berger J; Bellon G; Louis D; Münker G; Döring G
    Am J Respir Cell Mol Biol; 1998 Jul; 19(1):83-91. PubMed ID: 9651183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epithelium as a target for therapy in cystic fibrosis.
    Thelin WR; Boucher RC
    Curr Opin Pharmacol; 2007 Jun; 7(3):290-5. PubMed ID: 17475561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnosis of a conductive olfactory loss.
    Seiden AM; Duncan HJ
    Laryngoscope; 2001 Jan; 111(1):9-14. PubMed ID: 11192906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current concepts in therapy of chronic rhinosinusitis and nasal polyposis.
    Gosepath J; Mann WJ
    ORL J Otorhinolaryngol Relat Spec; 2005; 67(3):125-36. PubMed ID: 15942266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ear, nose and throat findings in cystic fibrosis patients.
    Ozçelik T; Ozgirgin N; Ozçelik U; Göçmen A; Gürcan B; Kiper N
    Turk J Pediatr; 1997; 39(1):51-4. PubMed ID: 10868193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophilic cationic protein as a marker of nasal inflammation in patients with cystic fibrosis.
    Weber A; Kiefer J; Peters S; Schneider M; Bargon J; May A
    Laryngoscope; 1999 Oct; 109(10):1696-702. PubMed ID: 10522945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
    Tarran R; Donaldson S; Boucher RC
    Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of cystic fibrosis. An update.
    Davis PB; di Sant'Agnese PA
    Chest; 1984 Jun; 85(6):802-9. PubMed ID: 6373170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective analysis of chronic rhinosinusitis in patients with cystic fibrosis.
    Gutiérrez C; Ribalta G; Largo I
    Acta Otorrinolaringol Esp; 2012; 63(4):286-91. PubMed ID: 22682652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Sinusitis in the Cystic Fibrosis Patient.
    Okafor S; Kelly KM; Halderman AA
    Immunol Allergy Clin North Am; 2020 May; 40(2):371-383. PubMed ID: 32278458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.